Treatment for Skin Fungal Infections

Introduction to Skin Fungal Infection Treatment

• Topical antifungal agents are the first-line treatment for most skin fungal infections, with specific systemic therapy reserved for extensive, resistant, or specific types of infections 1, 2

Treatment by Type of Skin Fungal Infection

• Topical azoles (clotrimazole, miconazole) and polyenes (nystatin) are effective for treating candidal skin infections, especially in skin folds of obese and diabetic patients 1, 3
• Keeping the infected area dry is crucial for successful treatment 1, 2
• For paronychia (infection around the nail), drainage is the most important intervention, followed by antifungal therapy 1, 3
• Topical agents are usually ineffective for nail infections 1
• Oral therapy is required for nail infections, with terbinafine or itraconazole preferred over griseofulvin for most cases 1
• For Candida onychomycosis specifically, azoles are preferred as terbinafine has limited activity 1

General Principles for Skin Fungal Infection Treatment

• Not keeping the infected area dry, particularly for intertrigo, can hinder treatment 1, 3
• Using topical therapy alone for nail infections or tinea capitis, which typically require systemic treatment, is not recommended 1

Treatment of Fungal Intertrigo

Initial Treatment Approach

• The Infectious Diseases Society of America recommends applying topical azole antifungals (clotrimazole, miconazole, ketoconazole, oxiconazole, or econazole) twice daily to affected areas for a minimum of 7-14 days, continuing for at least one week after clinical resolution 4
• Nystatin is equally effective as an alternative polyene antifungal for candidal intertrigo, according to the Infectious Diseases Society of America 4

Management of Underlying Risk Factors

• The American Diabetes Association and the Infectious Diseases Society of America suggest optimizing glycemic control in diabetic patients to prevent recurrence of fungal intertrigo 4, 5

Topical Antifungal Treatment

Introduction to Topical Antifungal Agents

• The Infectious Diseases Society of America recommends mikonazol as a first-line treatment for candida skin infections and paronychias, with a cure rate of 80-85%, in patients such as those with obesity and diabetes, particularly in intertriginous areas 6

Non-Dermatophyte Fungal Infections

• In vitro susceptibility tests show that mikonazol has a high level of activity against Aspergillus, ranking second after itraconazole, and superior to ketokonazol and terbinafine, which may be important in treating resistant nail infections 7
• The British Society for Medical Mycology suggests that mikonazol's activity against non-dermatophyte fungi, such as Aspergillus, is a significant advantage in the treatment of fungal infections 8

Treatment of Cutaneous Candidiasis

First-Line Topical Treatment

• Nystatin, a polyene antifungal, is equally effective as an alternative to topical azoles, with complete cure rates of 73-100% in patients with candidal skin infections, according to the Infectious Diseases Society of America 9, 10, 11

When to Consider Systemic Therapy

• Oral fluconazole 100-200 mg daily may be considered for extensive disease or when topical therapy fails, with a treatment duration of 7-14 days, as recommended by the Infectious Diseases Society of America 9, 10, 11

Treatment Duration and Monitoring

• Most uncomplicated cases of cutaneous candidiasis resolve within 7-14 days with appropriate topical therapy, and treatment should be continued for at least one week after all visible signs have cleared to prevent recurrence, as suggested by the Centers for Disease Control and Prevention 9, 10, 11

Best Initial Treatment for Intertrigo

Essential Non-Pharmacologic Measures

• Avoid hot showers and excessive soap use, which promote dehydration, as recommended by the Annals of Oncology 12
• Do not use alcohol-containing lotions or gels on inflamed intertriginous skin; use oil-in-water creams or ointments instead, as suggested by the Annals of Oncology 12

Risks of Inappropriate Topical Therapies in Intertrigo Management

Greasy Creams and Folliculitis Risk

• Using greasy creams for routine skin‑fold care can create an occlusive environment that promotes folliculitis development in patients with intertrigo. 13

Unsupervised Topical Steroid Use and Skin Atrophy

• Applying topical corticosteroids to intertriginous areas without dermatologic supervision carries a risk of skin atrophy when used for prolonged periods. 14